AyalewTefferiMD

PubMed

• Mayo Genetic Risk Models for Newly Diagnosed Acute Myeloid Leukemia Treated With Venetoclax + Hypomethylating Agent.
  Naseema Gangat, Azeem Elbeih, Nour Ghosoun, Kristen McCullough, Fnu Aperna
  American Journal of Hematology. 2024-12-13
• Peri-Transplant Management of JAK Inhibitor Therapy in Myelofibrosis.
  Ayalew Tefferi, Vincent T Ho
  American Journal of Hematology. 2024-12-12
• 1 citations
  PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosis.
  Ayalew Tefferi, Saubia Fathima, Ali Khalid A Alsugair, Fnu Aperna, Anuya Natu
  American Journal of Hematology. 2024-12-01

Abstracts/Posters

• Functional Interrogation of Variants of Undetermined Significance of the Isocitrate Dehydrogenase 1 and 2 Genes in Myeloid Neoplasms
  Ayalew Tefferi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Spectrum of Abnormalities and Clonal Transformation in Germline RUNX1 Familial Platelet Disorder and a Comparative Analysis with Somatic RUNX1 Mutations in Myeloid Neo...
  Ayalew Tefferi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Clinical Categorization of Chronic Myelomonocytic Leukemia into Proliferative and Dysplastic Subtypes Correlates with Distinct Genomic, Transcriptomic and Epigenomic S...
  Ayalew Tefferi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Acute Myeloid Leukemia with High Risk Features: Routine Central Nervous System Evaluation May be Beneficial
  Ayalew Tefferi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Phenotypic Correlates and Prognostic Outcomes of TET2 Mutations in Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes: A Comprehensive Study of 504...
  Ayalew Tefferi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Response to Erythropoiesis Stimulating Agents in Patients with WHO-Defined Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytos...
  Ayalew Tefferi, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Trainee Didactic Sessions: How to Set Up a Clinical Research Program 
  60th American Society of Hematology Annual Meeting - 12/3/2018
• Results from Ongoing Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Relapsed/Refractory Chronic Myelomonocytic Leukemia (CMML) 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• A Prospective Evaluation of Vitamin B1 (thiamine) Level in Myeloproliferative Neoplasms: Clinical Correlations and Impact of JAK2 Inhibitor Therapy 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Determinants of Long-Term Outcome in Type 1/like Calreticulin-Mutated Myelofibrosis 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Results from Ongoing Phase 1/2 Clinical Trial of Tagraxofusp (SL-401) in Patients with Intermediate or High Risk Relapsed/Refractory Myelofibrosis 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• The Germline JAK2 GGCC (46/1) Haplotype and Survival Among 414 Molecularly-Annotated Patients with Primary Myelofibrosis 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Cancer Medicine and Hematology 
  Harvard Medical School ,Department Of Continuing Education, Boston, Massachusetts - 9/29/2013
• Cancer Medicine and Hematology 
  Harvard Medical School ,Department Of Continuing Education, Boston, Massachusetts - 9/29/2013
• Join now to see all

Other

• Approach to the patient with thrombocytosis 
  Tefferi A
  http://www.uptodate.com/contents/approach-to-the-patient-with-thrombocytosis
  UpToDate, Wolters Kluwer Health - 2012-09-06
• Diagnostic approach to the patient with polycythemia 
  Tefferi A
  http://www.uptodate.com/contents/diagnostic-approach-to-the-patient-with-polycythemia
  UpToDate, Wolters Kluwer Health - 2012-11-09
• Diagnostic approach to the patient with suspected polycythemia vera 
  Tefferi A
  http://www.uptodate.com/contents/diagnostic-approach-to-the-patient-with-suspected-polycythemia-vera
  UpToDate, Wolters Kluwer Health - 2013-01-25
• Clinical manifestations and diagnosis of primary myelofibrosis 
  Tefferi A
  http://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-primary-myelofibrosis
  UpToDate, Wolters Kluwer Health - 2013-01-31
• Prognosis and treatment of primary myelofibrosis 
  Tefferi A
  http://www.uptodate.com/contents/prognosis-and-treatment-of-primary-myelofibrosis
  UpToDate, Wolters Kluwer Health - 2013-04-04
• Overview of the myeloproliferative neoplasms 
  Tefferi A
  http://www.uptodate.com/contents/overview-of-the-myeloproliferative-neoplasms
  UpToDate, Wolters Kluwer Health - 2013-04-12
• Diagnosis and clinical manifestations of essential thrombocythemia 
  Tefferi A
  http://www.uptodate.com/contents/diagnosis-and-clinical-manifestations-of-essential-thrombocythemia
  UpToDate, Wolters Kluwer Health - 2012-09-06
• Prognosis and treatment of essential thrombocythemia 
  Tefferi A
  http://www.uptodate.com/contents/prognosis-and-treatment-of-essential-thrombocythemia
  UpToDate, Wolters Kluwer Health - 2013-03-12
• Prognosis and treatment of polycythemia vera 
  Tefferi A
  http://www.uptodate.com/contents/prognosis-and-treatment-of-polycythemia-vera
  UpToDate, Wolters Kluwer Health - 2013-03-12
• Pathogenetic mechanisms in primary myelofibrosis 
  Tefferi A
  http://www.uptodate.com/contents/pathogenetic-mechanisms-in-primary-myelofibrosis
  UpToDate, Wolters Kluwer Health - 2013-04-12
• Join now to see all